Published in Neoplasia on February 01, 2008
Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res (2010) 1.23
CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia (2009) 1.21
CXCR4/CXCL12 participate in extravasation of metastasizing breast cancer cells within the liver in a rat model. PLoS One (2012) 0.98
Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis. Cell Adh Migr (2012) 0.95
In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction. BMC Cancer (2010) 0.92
A pentacyclic triterpene natural product, ursolic acid and its prodrug US597 inhibit targets within cell adhesion pathway and prevent cancer metastasis. Oncotarget (2015) 0.87
Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging. Bioorg Med Chem Lett (2010) 0.87
Intracellular targets of RGDS peptide in melanoma cells. Mol Cancer (2010) 0.85
Applications of snake venom components to modulate integrin activities in cell-matrix interactions. Int J Biochem Cell Biol (2013) 0.84
RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo. PLoS One (2011) 0.83
Disintegrins from snake venoms and their applications in cancer research and therapy. Curr Protein Pept Sci (2015) 0.83
Mechanisms involved in breast cancer liver metastasis. J Transl Med (2015) 0.82
Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling. PLoS One (2012) 0.81
Plumieribetin, a fish lectin homologous to mannose-binding B-type lectins, inhibits the collagen-binding alpha1beta1 integrin. J Biol Chem (2009) 0.79
RGDechi-hCit: αvβ3 selective pro-apoptotic peptide as potential carrier for drug delivery into melanoma metastatic cells. PLoS One (2014) 0.75
The War on Cancer rages on. Neoplasia (2009) 0.75
Dinosaurs and ancient civilizations: reflections on the treatment of cancer. Neoplasia (2010) 0.75
Neoplasia: the second decade. Neoplasia (2008) 0.75
Modeling the Kinetics of Integrin Receptor Binding to Hepatic Extracellular Matrix Proteins. Sci Rep (2017) 0.75
Integrins: bidirectional, allosteric signaling machines. Cell (2002) 36.25
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol (1996) 9.77
Role of integrins in cell invasion and migration. Nat Rev Cancer (2002) 7.64
Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet (2004) 5.47
Form and function: the laminin family of heterotrimers. Dev Dyn (2000) 4.38
Axis of evil: molecular mechanisms of cancer metastasis. Oncogene (2003) 2.81
Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut (1980) 2.24
Integrins in invasive growth. J Clin Invest (2002) 1.96
Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol (2006) 1.82
Cell attachment properties of collagen type VI and Arg-Gly-Asp dependent binding to its alpha 2(VI) and alpha 3(VI) chains. Exp Cell Res (1989) 1.77
Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta (1988) 1.75
An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation. J Gastrointest Surg (2003) 1.75
The extracellular matrix in hepatic regeneration. FASEB J (1995) 1.65
Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1alpha on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res (1997) 1.33
Integrity of actin fibers and microtubules influences metastatic tumor cell adhesion. Exp Cell Res (2004) 1.30
Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res (2003) 1.29
Recombinant soluble human alpha 3 beta 1 integrin: purification, processing, regulation, and specific binding to laminin-5 and invasin in a mutually exclusive manner. Biochemistry (1998) 1.23
alpha 2beta 1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J Biol Chem (2000) 1.20
Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. Am J Pathol (2002) 1.17
Integrins in cancer treatment. Curr Cancer Drug Targets (2006) 1.12
Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. Am J Pathol (2005) 1.07
Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer (2005) 1.06
The alpha2beta1 integrin inhibitor rhodocetin binds to the A-domain of the integrin alpha2 subunit proximal to the collagen-binding site. Biochem J (2003) 1.02
Mammary-carcinoma cells in mouse liver: infiltration of liver tissue and interaction with Kupffer cells. Br J Cancer (1978) 1.00
Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg (2004) 0.99
Role of integrin alpha(v)beta3 in the early phase of liver metastasis: PET and IVM analyses. Clin Exp Metastasis (2002) 0.99
Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components. Br J Cancer (1999) 0.99
Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential. J Cancer Res Clin Oncol (2004) 0.98
Expression of cell adhesion molecules, their ligands and tumour necrosis factor alpha in the liver of patients with metastatic gastrointestinal carcinomas. Histochem J (2002) 0.94
alphaV Integrins on HT-29 colon carcinoma cells: adhesion to fibronectin is mediated solely by small amounts of alphaVbeta6, and alphaVbeta5 is codistributed with actin fibers. Exp Cell Res (1997) 0.93
Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins. Hepatology (2001) 0.92
Collagen-binding integrins as pharmaceutical targets. Curr Pharm Des (2005) 0.91
Transient expression of laminin alpha1 chain in regenerating murine liver: restricted localization of laminin chains and nidogen-1. Exp Cell Res (2005) 0.88
Separate functions of alpha2beta1 and alpha3beta1 integrins in the metastatic process of human gastric carcinoma. Surg Today (1998) 0.86
Quantitative in vitro assay for tumor cell invasion through extracellular matrix or into protein gels. Cancer Res (1988) 0.85
Vipera lebetina venom contains two disintegrins inhibiting laminin-binding beta1 integrins. J Biol Chem (2003) 0.84
TA3/St, but not TA3/Ha, mammary carcinoma cell adhesion to hepatocytes is mediated by alpha 5 beta 1 interacting with surface-associated fibronectin. Cell Adhes Commun (1994) 0.84
Evaluation of hepatic microcirculation by in vivo microscopy. J Invest Surg (1999) 0.83
Tumour metastasis to the liver, and the roles of proteinases and adhesion molecules: new concepts from in vivo videomicroscopy. Can J Gastroenterol (1999) 0.83
The molecular basis of integrin-extracellular matrix interactions. Osteoarthritis Cartilage (2001) 0.82
Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV. Bioinformatics (2011) 5.45
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood (2005) 2.90
The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem (2007) 2.24
CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. J Immunol (2009) 1.80
Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg (2007) 1.79
Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol (2005) 1.73
Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol (2006) 1.61
Rhodocetin antagonizes stromal tumor invasion in vitro and other alpha2beta1 integrin-mediated cell functions. Matrix Biol (2002) 1.57
CLEC-2 activates Syk through dimerization. Blood (2010) 1.49
Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange. J Physiol (2005) 1.49
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol (2007) 1.43
Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol (2004) 1.39
Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer (2002) 1.38
Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network. Thromb Haemost (2007) 1.32
Integrity of actin fibers and microtubules influences metastatic tumor cell adhesion. Exp Cell Res (2004) 1.30
Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling. J Biol Chem (2010) 1.29
Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion. Cancer Res (2004) 1.23
CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol (2002) 1.21
Gab2-mediated signaling promotes melanoma metastasis. Am J Pathol (2009) 1.21
CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia (2009) 1.21
Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J Biol Chem (2008) 1.20
Integrins in cancer treatment. Curr Cancer Drug Targets (2006) 1.12
EGFL7 ligates αvβ3 integrin to enhance vessel formation. Blood (2013) 1.11
Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac. Blood (2010) 1.11
Latent TGF-beta1 activation by platelets. J Cell Physiol (2004) 1.08
Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. Am J Pathol (2005) 1.07
Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs. Biochem Biophys Res Commun (2003) 1.06
Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer (2005) 1.06
G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. J Biol Chem (2008) 1.06
The novel Drosophila lysosomal enzyme receptor protein mediates lysosomal sorting in mammalian cells and binds mammalian and Drosophila GGA adaptors. J Biol Chem (2005) 1.05
The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem (2012) 1.04
Tumour necrosis factor alpha confers an invasive, transformed phenotype on mammary epithelial cells. J Cell Sci (2005) 1.03
Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity. J Biol Chem (2007) 1.03
The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma? J Surg Oncol (2014) 1.02
Cytotoxicity and inhibition of platelet aggregation caused by an l-amino acid oxidase from Bothrops leucurus venom. Biochim Biophys Acta (2011) 1.01
Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg (2004) 0.99
The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2. J Biol Chem (2006) 0.98
A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation. Blood (2012) 0.98
CXCR4/CXCL12 participate in extravasation of metastasizing breast cancer cells within the liver in a rat model. PLoS One (2012) 0.98
GAB2 amplifications refine molecular classification of melanoma. Clin Cancer Res (2009) 0.97
Lumican inhibits cell migration through α2β1 integrin. Exp Cell Res (2010) 0.96
Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer. PLoS One (2009) 0.96
Deleted in malignant brain tumors 1 is present in the vascular extracellular matrix and promotes angiogenesis. Arterioscler Thromb Vasc Biol (2011) 0.95
Characterization of a conduit system containing laminin-5 in the human thymus: a potential transport system for small molecules. J Cell Sci (2006) 0.94
Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis. Int J Cancer (2011) 0.94
Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2. Protein Sci (2008) 0.93
Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin. J Biol Chem (2008) 0.93
Inactivation of active and latent transforming growth factor beta by free thiols: potential redox regulation of biological action. Int J Biochem Cell Biol (2006) 0.93
Recombinant human laminin-5 domains. Effects of heterotrimerization, proteolytic processing, and N-glycosylation on alpha3beta1 integrin binding. J Biol Chem (2003) 0.92
A novel flow cytometry-based platelet aggregation assay. Blood (2013) 0.92
Trimeric autotransporter adhesin-dependent adherence of Bartonella henselae, Bartonella quintana, and Yersinia enterocolitica to matrix components and endothelial cells under static and dynamic flow conditions. Infect Immun (2011) 0.91
The polarity protein Scrib is essential for directed endothelial cell migration. Circ Res (2013) 0.91
An arthritogenic alphavirus uses the alpha1beta1 integrin collagen receptor. Virology (2005) 0.91
Defective granulation tissue formation in mice with specific ablation of integrin-linked kinase in fibroblasts - role of TGFβ1 levels and RhoA activity. J Cell Sci (2010) 0.90
Functional comparison of single- and double-stranded siRNAs in mammalian cells. Biochem Biophys Res Commun (2004) 0.90
The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma. J Pathol (2004) 0.89
Interleukin (IL)-6 and IL-10 induce decorin mRNA in endothelial cells, but interaction with fibrillar collagen is essential for its translation. J Biol Chem (2004) 0.88
C-type lectin-like proteins from snake venoms. Toxicon (2012) 0.88
Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras. Mol Cell Biol (2005) 0.88
Matrilins mediate weak cell attachment without promoting focal adhesion formation. Matrix Biol (2006) 0.87
Prolyl hydroxylation of collagen type I is required for efficient binding to integrin alpha 1 beta 1 and platelet glycoprotein VI but not to alpha 2 beta 1. J Biol Chem (2003) 0.87
Decorin regulates endothelial cell-matrix interactions during angiogenesis. Cell Adh Migr (2009) 0.86
Structure and laminin-binding specificity of the NtA domain expressed in eukaryotic cells. Matrix Biol (2004) 0.86
The novel metalloproteinase atroxlysin-I from Peruvian Bothrops atrox (Jergón) snake venom acts both on blood vessel ECM and platelets. Arch Biochem Biophys (2010) 0.86
HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells. Biochem Biophys Res Commun (2004) 0.85
Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectin. J Pathol (2014) 0.85
Components of cell-matrix linkage as potential new markers for prostate cancer. Cancers (Basel) (2011) 0.85
GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy. Clin Exp Metastasis (2002) 0.85
Structural and functional characterization of a P-III metalloproteinase, leucurolysin-B, from Bothrops leucurus venom. Arch Biochem Biophys (2007) 0.85
The C-terminus of the gamma 2 chain but not of the beta 3 chain of laminin-332 is indirectly but indispensably necessary for integrin-mediated cell reactions. Exp Cell Res (2007) 0.84
Collagen XXIII, novel ligand for integrin alpha2beta1 in the epidermis. J Biol Chem (2011) 0.83
Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases. Cancer Lett (2006) 0.83
Hypoxia-inducible factor 1-regulated lysyl oxidase is involved in Staphylococcus aureus abscess formation. Infect Immun (2013) 0.83
The electrical resistance breakdown assay determines the role of proteinases in tumor cell invasion. Am J Physiol Renal Physiol (2002) 0.82
Binding and docking of synthetic heterotrimeric collagen type IV peptides with alpha1beta1 integrin. Chembiochem (2002) 0.82
Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis? Clin Exp Metastasis (2002) 0.82
Integrin α7β1 is a redox-regulated target of hydrogen peroxide in vascular smooth muscle cell adhesion. Free Radic Biol Med (2012) 0.82
The glycocalyx maintains a cell surface pH nanoenvironment crucial for integrin-mediated migration of human melanoma cells. Pflugers Arch (2009) 0.81
Critical Role for an acidic amino acid region in platelet signaling by the HemITAM (hemi-immunoreceptor tyrosine-based activation motif) containing receptor CLEC-2 (C-type lectin receptor-2). J Biol Chem (2012) 0.81
Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation. Biol Chem (2012) 0.81
Delay of acute intracellular pH recovery after acidosis decreases endothelial cell activation. J Cell Physiol (2007) 0.81
Matching IR-MALDI-o-TOF mass spectrometry with the TLC overlay binding assay and its clinical application for tracing tumor-associated glycosphingolipids in hepatocellular and pancreatic cancer. Anal Chem (2008) 0.81
Structural requirements of KTS-disintegrins for inhibition of alpha(1)beta(1) integrin. Biochem J (2009) 0.80
The collagen-binding integrin α2β1 is a novel interaction partner of the Trimeresurus flavoviridis venom protein flavocetin-A. J Biol Chem (2012) 0.80
Pharmacological aspects of Vipera xantina palestinae venom. Toxins (Basel) (2011) 0.80
Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation. J Oncol (2011) 0.79
Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer. Mol Cancer Ther (2008) 0.79
Extracellular matrix composition and interstitial pH modulate NHE1-mediated melanoma cell motility. Int J Oncol (2013) 0.79
Subtyping of breast cancer using reverse phase protein arrays. Expert Rev Proteomics (2014) 0.79
Plumieribetin, a fish lectin homologous to mannose-binding B-type lectins, inhibits the collagen-binding alpha1beta1 integrin. J Biol Chem (2009) 0.79
Mechanically enforced bond dissociation reports synergistic influence of Mn2+ and Mg2+ on the interaction between integrin α7β1 and invasin. J Mol Recognit (2011) 0.78
Quantitative codon optimisation of DNA libraries encoding sub-random peptides: design and characterisation of a novel library encoding transmembrane domain peptides. Nucleic Acids Res (2002) 0.78
Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound. Toxins (Basel) (2012) 0.78
Structural profiling of individual glycosphingolipids in a single thin-layer chromatogram by multiple sequential immunodetection matched with Direct IR-MALDI-o-TOF mass spectrometry. Anal Chem (2009) 0.78
Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscumin. FASEB J (2004) 0.78